Theravance Biopharma Inc (NASDAQ:TBPH)

22.06
Delayed Data
As of Apr 20
 -0.12 / -0.54%
Today’s Change
21.27
Today|||52-Week Range
43.44
-20.90%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close22.18
Today’s open21.93
Day’s range21.27 - 22.72
Volume221,640
Average volume (3 months)229,910
Market cap$1.6B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-27.93%
Earnings growth (this year)+19.36%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)-68.37%
P/E ratioNM
Price/Sales94.90
Price/Book13.51

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.58-3.19%
CBMCambrex Corp-0.05-0.09%
ARRYArray Biopharma Inc-0.35-2.42%
RGENRepligen Corp+0.19+0.51%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$1.03
Annual revenue (last year)$15.4M
Annual profit (last year)-$285.4M
Net profit margin-1,854.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Chief Financial Officer, Treasurer &
SVP
Renee D. Gala
Corporate headquarters
George Town, George Town

Forecasts